An Observational Study to Collect Data on How Aflibercept (Eylea) Given Using a Paediatric Dosing Device is Used in Preterm Babies With Retinopathy of Prematurity in the United Kingdom (UK)

RecruitingOBSERVATIONAL

Enrollment

200

Participants

Timeline

Start Date

March 5, 2024

Primary Completion Date

March 31, 2027

Study Completion Date

April 30, 2027

Conditions

Retinopathy of PrematurityPreterm Infants

Interventions

DRUG

Aflibercept (Eylea)

Eylea 40 mg/mL solution for injection in pre-filled syringe.

Trial Locations (1)

RECRUITING

Many locations, Multiple Locations